MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology

Clinical Studies of Robotic-assisted Surgery in Urology With MicroPort® Endoscopic Instrument Control System

Laparoscopy, now virtually completely, was replaced with robotic surgery in uro-oncological surgery in the world. And given the significant increase in the number of robotic surgeries for prostate, bladder and kidney cancer, it is now a major domain in oncological surgery. Microport MedBot Inc. has independently developed a domestic surgical robot in China. Therefore, the purpose of the study is to evaluate the safety and efficacy of the Chinese robot when applied to surgery in oncology.

Inclusion Criteria:

• be aged between 18 years and 80 years;
• laparoscopic surgery is required with one of the following surgical indications:(1)planning to perform radical prostatectomy(clinical stage is T1 or T2,and PSA≥ 0.2ng/mL) ;(2) planning to perform nephrectomy
• being able to cooperate and complete the follow-up and related examinations;
• volunteer to participate in this study and sign the informed consent.

Exclusion Criteria:

• patients requiring emergency surgery;
• have severe cardiovascular or circulatory disease and cannot tolerate surgery;
• participated in other clinical trials in the last 3 months;
• failure to understand study requirements